FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W335210161> ?p ?o ?g. }

• W335210161 endingPage "234" @default.
• W335210161 startingPage "229" @default.
• W335210161 abstract "CD133, putative cancer stem cell marker, deemed to aid chemoresistance. However, this claim has been challenged recently and we previously reported that patients with CD133(+) colon cancer have benefit from 5-fluorouracil (5-FU) chemotherapy incontrast to no benefit in patients with CD133(-) cancer. To elucidate the role of CD133 expression in chemoresistance, we silenced the CD133 expression in a colon cancer cell line and determined its effect on the biological characteristics downstream. We comparatively analyzed the sequential changes of MDR1, ABCG2, AKT1 and survivin expression and the result of proliferation assay (WST-1 assay) with 5-FU treatment in CD133(+) and siRNA-induced CD133(-) cells, derived from Caco-2 colon cancer cell line. 5-FU treatment induced significantly increase of the mRNA expression of MDR1, ABCG2 and AKT1genes, but not protein level. CD133 had little to no effect on the mRNA and protein expression of these genes. However, survivin expression at mRNA and protein level were significantly increased in CD133(+) cells compared with siRNA-induced CD133-cells and Mock (not sorted CD133(+) cells) at 96 h after siRNA transfection. The cytotoxicity assay demonstrated notable increase of chemoresistance to 5-FU treatment (10 μM) in CD133(+) cells at 96 h after siRNA transfection. From this study, we conclude that CD133(+) cells may have chemoresistance to 5-FU through the mechanism which is related with survivin expression, instead of MDR1, ABCG2 and AKT1 expression. Therefore a survivin inhibitor can be a new target for effective treatment of CD133(+) colon cancer." @default.
• W335210161 created "2016-06-24" @default.
• W335210161 creator A5024294695 @default.
• W335210161 creator A5026021259 @default.
• W335210161 creator A5045406597 @default.
• W335210161 creator A5084107763 @default.
• W335210161 date "2015-07-01" @default.
• W335210161 modified "2023-09-27" @default.
• W335210161 title "Chemoresistance of CD133 + colon cancer may be related with increased survivin expression" @default.
• W335210161 cites W107638423 @default.
• W335210161 cites W116758555 @default.
• W335210161 cites W1972932862 @default.
• W335210161 cites W1981177118 @default.
• W335210161 cites W1983961550 @default.
• W335210161 cites W2000245494 @default.
• W335210161 cites W2003727125 @default.
• W335210161 cites W2003832896 @default.
• W335210161 cites W2013251203 @default.
• W335210161 cites W2014871497 @default.
• W335210161 cites W2016797632 @default.
• W335210161 cites W2019768326 @default.
• W335210161 cites W2022881840 @default.
• W335210161 cites W2045713322 @default.
• W335210161 cites W2051362535 @default.
• W335210161 cites W2060540057 @default.
• W335210161 cites W2062069198 @default.
• W335210161 cites W2070059442 @default.
• W335210161 cites W2073847012 @default.
• W335210161 cites W2081447858 @default.
• W335210161 cites W2083479805 @default.
• W335210161 cites W2092595618 @default.
• W335210161 cites W2109865330 @default.
• W335210161 cites W2112496815 @default.
• W335210161 cites W2119905096 @default.
• W335210161 cites W2147286291 @default.
• W335210161 cites W2165149380 @default.
• W335210161 cites W2167414381 @default.
• W335210161 cites W2205733027 @default.
• W335210161 cites W2265716186 @default.
• W335210161 doi "https://doi.org/10.1016/j.bbrc.2015.05.031" @default.
• W335210161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26002465" @default.
• W335210161 hasPublicationYear "2015" @default.
• W335210161 type Work @default.
• W335210161 sameAs 335210161 @default.
• W335210161 citedByCount "32" @default.
• W335210161 countsByYear W3352101612016 @default.
• W335210161 countsByYear W3352101612017 @default.
• W335210161 countsByYear W3352101612018 @default.
• W335210161 countsByYear W3352101612019 @default.
• W335210161 countsByYear W3352101612020 @default.
• W335210161 countsByYear W3352101612021 @default.
• W335210161 countsByYear W3352101612022 @default.
• W335210161 countsByYear W3352101612023 @default.
• W335210161 crossrefType "journal-article" @default.
• W335210161 hasAuthorship W335210161A5024294695 @default.
• W335210161 hasAuthorship W335210161A5026021259 @default.
• W335210161 hasAuthorship W335210161A5045406597 @default.
• W335210161 hasAuthorship W335210161A5084107763 @default.
• W335210161 hasConcept C104317684 @default.
• W335210161 hasConcept C105580179 @default.
• W335210161 hasConcept C121608353 @default.
• W335210161 hasConcept C149011108 @default.
• W335210161 hasConcept C153911025 @default.
• W335210161 hasConcept C185592680 @default.
• W335210161 hasConcept C2775975398 @default.
• W335210161 hasConcept C44312359 @default.
• W335210161 hasConcept C502942594 @default.
• W335210161 hasConcept C512196 @default.
• W335210161 hasConcept C526805850 @default.
• W335210161 hasConcept C54009773 @default.
• W335210161 hasConcept C54355233 @default.
• W335210161 hasConcept C55427017 @default.
• W335210161 hasConcept C55493867 @default.
• W335210161 hasConcept C81885089 @default.
• W335210161 hasConcept C86803240 @default.
• W335210161 hasConcept C96232424 @default.
• W335210161 hasConceptScore W335210161C104317684 @default.
• W335210161 hasConceptScore W335210161C105580179 @default.
• W335210161 hasConceptScore W335210161C121608353 @default.
• W335210161 hasConceptScore W335210161C149011108 @default.
• W335210161 hasConceptScore W335210161C153911025 @default.
• W335210161 hasConceptScore W335210161C185592680 @default.
• W335210161 hasConceptScore W335210161C2775975398 @default.
• W335210161 hasConceptScore W335210161C44312359 @default.
• W335210161 hasConceptScore W335210161C502942594 @default.
• W335210161 hasConceptScore W335210161C512196 @default.
• W335210161 hasConceptScore W335210161C526805850 @default.
• W335210161 hasConceptScore W335210161C54009773 @default.
• W335210161 hasConceptScore W335210161C54355233 @default.
• W335210161 hasConceptScore W335210161C55427017 @default.
• W335210161 hasConceptScore W335210161C55493867 @default.
• W335210161 hasConceptScore W335210161C81885089 @default.
• W335210161 hasConceptScore W335210161C86803240 @default.
• W335210161 hasConceptScore W335210161C96232424 @default.
• W335210161 hasFunder F4320322348 @default.
• W335210161 hasIssue "3" @default.
• W335210161 hasLocation W3352101611 @default.
• W335210161 hasLocation W3352101612 @default.

• next